Volume 112, Issue 1

Search all Clinical Research in Cardiology articles

January 2023

Spotlight: Heart Failure

Filter by

Volume:

Sort by

Date published:

New to old Old to new

15 articles in this issue

Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography
A. Hagendorff
A. Helfen
S. Ewen
Review Open access 04 June 2022 Pages: 1 - 38
Heart failure-related quality-of-life impairment after myocardial infarction
Peter Wohlfahrt
Dominik Jenča
Josef Kautzner
Original Paper 18 March 2022 Pages: 39 - 48
Symptom burden, psychosocial distress and palliative care needs in heart failure – A cross-sectional explorative pilot study
F. Strangl
E. Ischanow
M. Rybczynski
Original Paper Open access 14 April 2022 Pages: 49 - 58
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
Guido Grassi
Gino Seravalle
Giuseppe Mancia
Original Paper Open access 12 May 2022 Pages: 59 - 67
Reliability of estimating left ventricular ejection fraction in clinical routine: a validation study of the SWEDEHEART registry
Joel Lenell
Bertil Lindahl
Tomasz Baron
Original Paper Open access 17 May 2022 Pages: 68 - 74
Lack of correlation between different congestion markers in acute decompensated heart failure
Svenja Haag
Alexander Jobs
Holger Thiele
Original Paper Open access 01 June 2022 Pages: 75 - 86
Body fluid regulation via chronic inhibition of sodium–glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial
Shinya Fujiki
Atsushi Tanaka
the CANDLE Trial Investigators
Original Paper 22 June 2022 Pages: 87 - 97
Nighttime hemodynamic phenotype. A novel risk factor for cardiovascular disease, especially heart failure: the practitioner-based nationwide JAMP study
Kazuomi Kario
Satoshi Hoshide
the JAMP Study Group
Original Paper 27 June 2022 Pages: 98 - 110
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Sam Straw
Charlotte A. Cole
John Gierula
Original Paper Open access 04 July 2022 Pages: 111 - 122
Comorbidities complicating heart failure: changes over the last 15 years
Elles M. Screever
Martje H. L. van der Wal
Wouter C. Meijers
Original Paper Open access 17 August 2022 Pages: 123 - 133
The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial
Julie Kolwelter
Dennis Kannenkeril
Roland E. Schmieder
Original Paper Open access 26 October 2022 Pages: 134 - 144
Clinical trajectories and outcomes of patients with heart failure with preserved ejection fraction with normal or indeterminate diastolic function
Bolrathanak Oeun
Shungo Hikoso
the OCVC-Heart Failure Investigators
Original Paper 10 November 2022 Pages: 145 - 157
Defining the gap in heart failure treatment in patients with cardiac implantable electronic devices
Samaneh Salimian
Nima Moghaddam
Nathaniel M. Hawkins
Original Paper 03 November 2022 Pages: 158 - 166
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Michael Fu
Aldina Pivodic
Lars H. Lund
Original Paper Open access 29 November 2022 Pages: 167 - 174
Correction: Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
Guido Grassi
Gino Seravalle
Giuseppe Mancia
Correction Open access 23 November 2022 Pages: 175 - 175

Volume 112, Issue 1

Search

Navigation